Rifat Pamukcu

This profile gathers the share dealings of Rifat Pamukcu in Aprea Therapeutics, Inc. Over a trading history stretching from 28 July 2022 to 16 June 2026, the count stands at 5 filings.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 17 June 2026 came the latest disclosure, a share grant in Aprea Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.